C12Q2600/124

CANID MICROBIOME MONITORING TOOLS AND DIAGNOSTIC METHODS

Methods for assessing a canid's microbiome health are provided. The methods include, inter alia, detecting at least four bacterial taxa in a sample obtained from the canid.

ISOLATION OF FETAL CELLS
20230295683 · 2023-09-21 ·

This disclosure generally relates to isolation of fetal cells from biological samples. Methods of using the enriched fetal cells for detecting genetic or epigenetic abnormalities or variations are also provided herein.

Hybrid tomato variety 72-MP0023 RZ

The present invention relates to a Solanum lycopersicum seed designated 72-MP0023 RZ. The present invention also relates to a Solanum lycopersicum plant produced by growing the 72-MP0023 RZ seed. The invention further relates to methods for producing the tomato cultivar, represented by tomato variety 72-MP0023 RZ.

Use of a gut microbiome as a predictor of animal growth or health

The present technology encompasses systems for predicting a characteristic of an individual subject, as well as methods for predicting a characteristic of a particular subject based on the systems of the technology disclosed herein. The disclosure herein also provides methods to improve a characteristics in a subject, based on the prediction produced by the system.

METHODS FOR IMPROVING THE HEALTH OF PORCINE SPECIES BY TARGETED INACTIVATION OF CD163

The present disclosure relates methods and compositions useful for prevention of porcine reproductive and respiratory syndrome virus (PRRSv) in animals, including animals of the species Sus scrofa. The present teachings relate to swine wherein at least one allele of a CD163 gene has been inactivated, and to specific methods and nucleic acid sequences used in gene editing to inactivate the CD163 gene. Swine wherein both alleles of the CD163 gene are inactivated are resistant to porcine reproductive and respiratory syndrome virus (PRRSv). Elite lines comprising homozygous CD163 edited genes retain their superior properties

METHODS AND SYSTEMS FOR INFERRING BOVINE TRAITS

Methods, compositions, and systems are provided for managing bovine subjects in order to maximize their individual potential performance and edible meat value, and to maximize profits obtained in marketing the bovine subjects. The methods and systems draw an inference of a trait of a bovine subject by determining the nucleotide occurrence of at least one bovine SNP that is identified herein as being associated with the trait. The inference is used in methods of the present invention to establish the economic value of a bovine subject, to improve profits related to selling beef from a bovine subject; to manage bovine subjects, to sort bovine subjects; to improve the genetics of a bovine population by selecting and breeding of bovine subjects, to clone a bovine subject with a specific trait, to track meat or another commercial product of a bovine subject; and to diagnose a health condition of a bovine subject. Methods are also disclosed for identifying additional SNPs associated with a trait, by using the associated SNPs identified herein.

Method for identifying racehorse using microsatellite marker

Provided is a method for identifying a racehorse including amplifying a target gene by a multiplex PCR using a microsatellite marker obtained by combining one or more sets selected from a first set consisting of AHT4, AHT5, ASB2, HMS3, HMS6, HMS7, HTG4, HTG10, VHL20, ASB17, ASB23, HMS1, LEX3, CA425, HMS2, HTG6, HTG7, LEX033, AMEL, HMS18, LEX27, SRY, and LEX020 and a second set consisting of HTG21, COR089, TKY279, TKY287, TKY294, TKY297, TKY301, TKY312, TKY321, TKY325, TKY333, TKY337, TKY341, TKY343, TKY344, TKY374, and TKY394; detecting alleles in the product amplified in the multiplex PCR amplification step and analyzing the sizes of the alleles using an electrophoresis apparatus to determine a genotype of the racehorse; and summarizing the sizes of the alleles analyzed using the electrophoresis apparatus according to the population and breed of racehorses to plot the number and a frequency distribution of the alleles based on the summarized results.

SNP MOLECULAR MARKER RELATED TO SINIPERCA CHUATSI INFECTIOUS SPLEEN AND KIDNEY NECROSIS VIRUS RESISTANCE, DETECTION METHOD AND USE THEREOF
20230332248 · 2023-10-19 ·

The invention relates to an SNP molecular marker located on a Siniperca chuatsi IFN-α3 gene and related to S. chuatsi infectious spleen and kidney necrosis virus (ISNKNV) resistance. On the basis of known cDNA, cloning is further carried out, an intron and a gDNA sequence of the S. chuatsi IFN-α3 gene are obtained, a primer is designed according to the gDNA sequence of IFN-α3, and through product amplification, and sequencing and alignment, SNP sites related to the disease-resistant or disease-susceptible characteristic of S. chuatsi germplasm are determined. Whereby, disease-resistant or disease-susceptible S. chuatsi germplasm can be rapidly screened out. The invention solves the problem of lack of the fish IFN-α3 gene, and also provides a theoretical basis and an operation method for breeding of disease-resistant germplasm by utilizing the heredity of the SNP sites and the correlation between the SNP sites and the disease-resistant characteristic.

MOLECULAR MARKER FOR GENETIC RESISTANCE OF CHICKEN TO INFECTION BY SUBGROUPS A AND K AVIAN LEUKOSIS VIRUS AND USE THEREOF

Disclosed is a molecular marker for genetic resistance of chicken to infection by subgroups A and K avian leukosis virus (ALV-A and ALV-K) and use thereof the molecular marker is tva gene with base deletion between 318-323 and/or between 602-607; specifically, bases ACCTCC at positions 318-323 and bases CCGCTG at positions 602-607 are deleted. In the present disclosure, genetic variation of tva receptor gene in Chinese chicken breeds is analyzed, and it is found that the DNA sequence of tva receptor gene in the Chinese chicken breeds has base deletion at positions 318-323 or at positions 602-607. Moreover, a method for breeding of the chicken breeds resistance to ALV-A and ALV-K has been established.

GENETIC TESTING FOR INHERITED PERIPHERAL NEUROPATHY
20230014028 · 2023-01-19 ·

Methods for diagnosing propensity to exhibit acquired peripheral neuropathy in dogs are described. The methods and kits test dogs for presence of a disease-associated genomic variant. Presence of the genomic variant indicates an increased likelihood of the dog developing an acquired peripheral neuropathy. This information can be used to guide preemptive clinical treatment of the animal for peripheral neuropathy and to choose dogs for selective breeding programs.